Monoclonal antibodies in development in multiple sclerosis
Introduction: The last fifteen years have seen the gradual appearance of a number of different drugs that have been shown to be effective as disease modifying therapies in multiple sclerosis. The opening and subsequent widening of the therapeutic armamentarium in multiple sclerosis will continue on...
Main Authors: | J. Sastre-Garriga, X. Montalban |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier España
2011-11-01
|
Series: | Neurología (English Edition) |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2173580811000393 |
Similar Items
-
Monoclonal Antibodies for Multiple Sclerosis Treatment
by: Filipe Palavra
Published: (2015-09-01) -
MONOCLONAL ANTIBODY FOR MULTIPLE SCLEROSIS TREATMENT
by: E. V. Popova
Published: (2017-05-01) -
Anticuerpos monoclonales en desarrollo en esclerosis múltiple
by: J. Sastre-Garriga, et al.
Published: (2011-11-01) -
Monoclonal Antibodies in Multiple Sclerosis: Present and Future
by: Natalia V. Voge, et al.
Published: (2019-03-01) -
Monoclonal antibodies in multiple sclerosis treatment: current and future steps
by: Claire L. Helliwell, et al.
Published: (2009-07-01)